IQVIA Pharma Deals Review of 2023
By Lucy Haggerty, Ayush Saxena & Taskin Ahmed
Pharma Deals Review: Vol 2024 Issue 3 (Table of Contents)
Published: 28 Mar-2024
DOI: 10.3833/pdr.v2024.i3.2867 ISSN: 1756-7874
Section: Opinion & Analysis
Fulltext:
Abstract
After reaching a multiyear low in 2022, deal activity in the life sciences sector continued to slow in 2023 as challenging headwinds persisted, deterring companies from signing M&A, licensing and collaborative R&D deals over the course of the year...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS